ArticleEuropean journal of medical research2025
Prognostic significance of postoperative glycemic variability after gastric surgery: a retrospective cohort study and development of a mortality prediction model.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGastric surgery is a critical intervention for conditions, such as gastric cancer, obesity, and peptic ulcer disease. Despite advances in surgical techniques and perioperative care, postoperative complications, including elevated mortality, remain a major concern. Glycemic variability (GV), calculated as the coefficient of variation of blood glucose levels during the ICU stay, has emerged as a potential predictor of adverse outcomes in critically ill patients. This study aimed to investigate the association between GV and postoperative mortality in patients undergoing gastric surgery.
methodsData were obtained from the MIMIC-IV database, which contains anonymized health records of ICU patients admitted to Beth Israel Deaconess Medical Center. The cohort included adult patients admitted to the ICU following gastric surgery. GV was assessed using the coefficient of variation of all recorded blood glucose measurements during the ICU stay. The primary outcome was 30-day all-cause in-hospital mortality; the secondary outcome was 90-day mortality. Associations between GV and outcomes were analyzed using Cox proportional hazards models and Kaplan-Meier survival analysis. In addition, machine learning models were developed to evaluate the predictive value of GV.
resultsA total of 1099 patients were included. Higher GV was significantly associated with increased 30-day and 90-day mortality (HR 1.15, 95% CI 1.09-1.21; and HR 1.14, 95% CI 1.09-1.20, respectively). Threshold analysis identified inflection points at GV = 20.24 for 30-day mortality and GV = 33.96 for 90-day mortality. The stacking ensemble model incorporating GV achieved strong predictive performance, with an area under the receiver operating characteristic curve (AUC) of 0.83.
conclusionsGV is a significant and independent predictor of postoperative mortality in gastric surgery patients. The observed threshold effects suggest that maintaining GV below critical levels may improve early outcomes. These findings highlight the prognostic value of GV and support its potential as a target for postoperative management. Further prospective, multicenter studies are warranted to validate these results and guide clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.